Posted on 9/12/19
East Lancashire Hospitals NHS Trust Joins TriNetX
East Lancashire Hospitals NHS Trust (ELHT), a large integrated healthcare organization serving over a half million patients in north west England, has joined the TriNetX global . . .
Posted on 9/12/19
Corvia Medical and physIQ Partner
BOSTON--(BUSINESS WIRE)--Corvia Medical has sponsored and is actively enrolling patients in an innovative heart failure (HF) device trial that, in addition to measuring traditional heart failure . . .
Posted on 9/11/19
NanoView Biosciences and Quantum Design Korea Enter Into Distribution Agreement
BOSTON--(BUSINESS WIRE)--NanoView Biosciences, Inc., and Quantum Design Korea, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView platform in South . . .
Posted on 9/10/19
Pharmco Announces Connecticut Bioprocessing Wing Expansion
Pharmco, a leading international producer of specialty alcohols and high purity solvents, announced an expansion to its packaging facility in Brookfield, Connecticut, through the creation of . . .
Posted on 9/10/19
Why Abiomed Stock Plunged 31% in August
What happenedAbiomed (NASDAQ:ABMD) stock plummeted 30.7% in August, according to data from S&P Global Market Intelligence.Shares of the Massachusetts-based maker of minimally invasive heart pumps are . . .
Posted on 9/10/19
Health Products For You Makes the Inc. 5000 List for the Second Consecutive Year
Health Products For You (HPFY), a leading health and wellness e-commerce company, marked its second appearance in a row on the Inc 5000 list. HPFY, headquartered . . .
Posted on 9/9/19
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics
Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA) therapeutic platform, announced today . . .
Posted on 9/9/19
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics
Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA) therapeutic platform, announced today . . .
Posted on 9/9/19
KalVista Pharmaceuticals Reports Fiscal First Quarter Results
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease . . .
Posted on 9/9/19
Platelet BioGenesis Raises $26 Million in Series A-1 Financing
Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+) and platelet-based therapeutics
Posted on 9/9/19
Is Bristol-Myers Squibb a Buy?
Bristol-Myers Squibb (NYSE:BMY) isn't having a great year. The big pharma stock has spent most of 2019 in negative territory. Many investors weren't happy with the . . .
Posted on 9/8/19
uniQure Announces Pricing of its Public Offering
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 05, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients . . .
Posted on 9/8/19
uniQure Announces Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 04, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients . . .
Posted on 9/8/19
42 North Dental Adds Three Affiliated Practices in Massachusetts
42 North Dental, a leading Dental Support Organization in New England, has added All Dental Center in Westborough and Watertown and Fresh Pond Dental in Cambridge . . .
Posted on 9/15/19
Peak Physical Therapy & Sports Performance Announces New Pediatric Pelvic Health Program
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, has . . .
Posted on 9/5/19
Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical Payoff
Vertex Pharmaceuticals (NASDAQ:VRTX) holds a virtual monopoly in treating cystic fibrosis (CF). But the successful biotech isn't content with winning in only one therapeutic area. Vertex . . .
Posted on 9/4/19
Resonetics Acquires Tru Tech Systems
Resonetics announced today that it has acquired Tru Tech Systems, Inc., based in Michigan, a leading supplier of precision grinding services for the medical device market . . .
Posted on 9/4/19
Iora Health and Humana Expand Relationship
BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Medicare Advantage members have additional access to high-impact, relationship-based primary care thanks to Iora Health and Humana Inc. (NYSE: HUM) teaming . . .
Posted on 9/4/19
Great Hill Partners Completes Recapitalization of Pareto Health
Pareto Health, Inc., a leading employee benefit group captive manager that helps businesses with 50+ employees self-fund health benefits with greater savings and lower volatility, today announced . . .
Posted on 9/4/19
Repare Therapeutics Raises $82.5M Series B Financing
Repare Therapeutics, a precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations, announced today the completion of a US$82.5 million
Posted on 9/2/19
Imprivata and Vocera Partner to Advance Mobility in Healthcare
Secure and convenient authentication helps optimize care coordination and clinical communicationsImprivata®, the healthcare IT security company, and Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical . . .
Posted on 8/28/19
Bristol-Myers Squibb: Great Deal On Celgene And Undervalued
SummaryIn January 2019, Bristol-Myers Squibb announced it will acquire Celgene and the acquisition will be closed at the end of 2019 or beginning of 2020.With important . . .
Posted on 8/27/19
Kintai Therapeutics Announces Collaborations with Leading Academic Centers
CAMBRIDGE, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that it has established new collaborations with leading academic institutions . . .
Posted on 8/27/19
ZOLL Medical Completes Acquisition of Cardiac Science
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously . . .
Posted on 8/27/19
Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win
Amgen (NASDAQ:AMGN) CEO Bob Bradway said in the big biotech's second-quarter conference call last monththat Amgen was "looking at ways to grow through business development." We . . .

